Literature DB >> 15975770

The C2 variant of human serum transferrin retains the iron binding properties of the native protein.

Paolo Zatta1, Luigi Messori, Pierluigi Mauri, Susan J van Rensburg, Johann van Zyl, Silvia Gabrielli, Chiara Gabbiani.   

Abstract

The tryptic digests of blood samples obtained from transferrin C1 and C2 (TfC 1 and TfC2 hereafter) genotypes were analysed by Liquid Chromatography coupled to Electrospray Mass Spectrometry (LC/ESI--MS/MS). The analytical results confirmed the single base change in exon 15 of the Tf gene. The solution behaviour and the iron binding properties of the two Tf variants were studied by UV-visible spectrophotometry and by circular dichroism. It appears that TfC2 globally manifests the same spectral features as the native protein. The local conformation of the two iron binding sites is conserved in the two Tf variants as evidenced by the visible absorption and CD spectra. Also, the iron binding capacities and their pH-dependent profiles are essentially the same. Overall, our investigation points out that the single amino acid substitution in TfC2 (Pro 570 Ser) does not affect the general conformation of the protein nor the local structure of the iron binding sites. The implications of these results for the etiopathogenesis of Alzheimer's disease are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15975770     DOI: 10.1016/j.bbadis.2005.04.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.

Authors:  J S K Kauwe; S Bertelsen; K Mayo; C Cruchaga; R Abraham; P Hollingworth; D Harold; M J Owen; J Williams; S Lovestone; J C Morris; A M Goate
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

2.  Iron genes, iron load and risk of Alzheimer's disease.

Authors:  D J Lehmann; M Worwood; R Ellis; V L J Wimhurst; A T Merryweather-Clarke; D R Warden; A D Smith; K J H Robson
Journal:  J Med Genet       Date:  2006-10       Impact factor: 6.318

3.  Escape from bacterial iron piracy through rapid evolution of transferrin.

Authors:  Matthew F Barber; Nels C Elde
Journal:  Science       Date:  2014-12-12       Impact factor: 47.728

4.  Hepcidin (rs10421768), Transferrin (rs3811647, rs1049296) and Transferrin Receptor 2 (rs7385804) Gene Polymorphism Might Be Associated with the Origin of Multiple Sclerosis.

Authors:  Laura Stachowska; Dorota Koziarska; Beata Karakiewicz; Artur Kotwas; Anna Knyszyńska; Marcin Folwarski; Karolina Dec; Ewa Stachowska; Viktoria Hawryłkowicz; Monika Kulaszyńska; Joanna Sołek-Pastuszka; Karolina Skonieczna-Żydecka
Journal:  Int J Environ Res Public Health       Date:  2022-06-04       Impact factor: 4.614

5.  Assessment of Alzheimer's disease case-control associations using family-based methods.

Authors:  Brit-Maren M Schjeide; Matthew B McQueen; Kristina Mullin; Jason DiVito; Meghan F Hogan; Michele Parkinson; Basavaraj Hooli; Christoph Lange; Deborah Blacker; Rudolph E Tanzi; Lars Bertram
Journal:  Neurogenetics       Date:  2008-10-02       Impact factor: 2.660

6.  Effect modification by transferrin C2 polymorphism on lead exposure, hemoglobin levels, and IQ.

Authors:  Ananya Roy; Adrienne S Ettinger; Howard Hu; David Bellinger; Joel Schwartz; Rama Modali; Robert O Wright; Kavitha Palaniappan; Kalpana Balakrishnan
Journal:  Neurotoxicology       Date:  2013-05-31       Impact factor: 4.294

Review 7.  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.

Authors:  Catherine M Cahill; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  Biochim Biophys Acta       Date:  2008-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.